The 2026 Healthtech Messaging Index
Regard
regard.com·scored August 23, 2026
28/38
Approaching
Close. The bones are good. A few targeted fixes on the weakest signals would push Regard into magnetic territory.
The page we scored
The AI Recommendation Check
When we asked AI who to recommend for AI-powered clinical documentation and diagnosis intelligence software for health systems, it named:
Buyer we put in the prompt: Chief Medical Information Officer, CMO, or VP of Revenue Cycle at a mid-to-large U.S. health system. Both the buyer and the category were inferred from Regard’s homepage alone. The model had no web access.
Regard was not on the list.
A buyer who asked AI this question got 8 names and moved on. Regard never came up.
We asked AI who it recommends for "Chief Medical Information Officer, CMO, or VP of Revenue Cycle at a mid-to-large U.S. health system" looking for "AI-powered clinical documentation and diagnosis intelligence software for health systems". It named Nuance DAX, Abridge, Suki, Ambience Healthcare, Augmedix. You did not appear. AI can't recommend what it can't clearly understand.
Overall assessment
Regard's biggest strength is its proof density ... the 3%-vs-100% stat, named dollar outcomes ($50M revenue earned, $9.3M denials prevented), attributed testimonials, and mechanistic AI framing combine into one of the more credible health tech pages available. The biggest gap is ICP precision and competitive framing: the page never tells a specific buyer role (CMO vs. CFO vs. CIO) why it's written for them, and it never acknowledges what health systems are doing today instead ... leaving no bridge between the buyer's current reality and Regard's offer.
Signal by category
Narrative Clarity
8 signals
Trust Signal
4 signals
AI Signal
6 signals
Conversion Signal
1 signal
Weakest signal · fix this first
12Alternatives Acknowledged
“No mention of competitors, CDI vendors, manual review processes, or 'do nothing' alternative anywhere on the page.”
The page never acknowledges what buyers are currently doing instead ... no competitor names, no 'vs. manual CDI' framing, no honest treatment of alternatives.
All 19 signals, scored 0 to 2.
Total 28/38
Narrative Clarity
8 signals
- 2
01The 7-Second Test
“Your revenue problem is a diagnosis problem”
The headline reframes a known hospital pain (lost revenue) as a diagnosis gap, and the subhead explains Regard reviews 100% of chart data ... who it's for, what it does, and the POV land in under 7 seconds.
- 2
02Rebellion / Movement
“Physicians only see 3% of data in the chart leading to missed diagnoses, sub-optimal care, and lost revenue”
The page explicitly names the status quo enemy ... the structural blindspot in physician chart review ... and positions Regard as the correction, giving it a clear missionary stance.
- 1
03Owned Language & Category
“Complete clinical picture" / "Clinical Concept Platform" / "Diagnostic intelligence layer”
Regard uses several branded-sounding phrases but none are consistently owned or defined as a named category an LLM would quote back; 'complete clinical picture' is repeated but never crowned as a proprietary framework.
- 1
04ICP Clarity
“Regard works for the whole health system" ... Clinical Notes, Mid-Revenue Cycle, HCC Capture, Screening”
The page signals health systems broadly but never specifies hospital size, bed count, system type, or the specific buyer role (CMO, CFO, CIO) ... a CFO and a CMIO would both see themselves here, which means neither feels directly addressed.
- 2
05Problem Leadership
“Physicians only see 3% of data in the chart leading to missed diagnoses, sub-optimal care, and lost revenue”
The page leads with the buyer's problem ... missed diagnoses causing revenue loss ... before introducing the solution, and the 3% statistic makes the problem viscerally concrete.
- 2
06Solution Clarity
“Regard reviews all data in the chart to recommend diagnoses ... generating a complete clinical picture for care and revenue cycle workflows”
A visitor can repeat exactly what Regard does in one sentence after reading the hero; the mechanism (reviews all chart data, recommends diagnoses) is explicit.
- 1
07Cost of Inaction
“missed diagnoses, sub-optimal care, and lost revenue”
The cost of inaction is named (lost revenue, missed diagnoses) but the page doesn't quantify the average cost of doing nothing ... no 'hospitals lose $X per year without this' framing to sharpen the stakes.
- 1
08Promised Land
“Catch missed diagnoses at the point of care, before they become queries or denials”
The after-state is implied (fewer denials, better documentation, more revenue) but never painted as a vivid, specific promised land ... there's no 'imagine your team's world when...' narrative arc.
Trust Signal
4 signals
- 2
09Proof & Evidence
“$50m+ in revenue earned" / "$9.3m in denials prevented" / "17% increase in CC/MCC capture" / "4x ROI per user”
Multiple named, specific, numeric outcomes with attributed health systems make this one of the strongest proof sections on the page.
- 2
10Social Proof
“Dr. Rollin Reeder, Associate Chief Medical Information Officer, Sentara Health" with video and named case study”
Testimonials include full name, title, organization, video, and linked case studies ... the social proof is specific, attributed, and multi-format.
- 1
11Authority & Credibility
“Recognized Among the World's Most Innovative Companies" / "Named to the Digital Health 100" / "Honored as One of Healthcare's Most Notable Leaders”
Third-party awards are present but founder credentials, original research, or proprietary clinical frameworks are absent; authority is claimed via awards rather than demonstrated through expertise.
- 0
12Alternatives Acknowledgedweakest
“No mention of competitors, CDI vendors, manual review processes, or 'do nothing' alternative anywhere on the page.”
The page never acknowledges what buyers are currently doing instead ... no competitor names, no 'vs. manual CDI' framing, no honest treatment of alternatives.
AI Signal
6 signals
- 2
13Customer Focus
“Regard's real value is that it improves patient care. It shrinks my blindspot, finding things I would otherwise miss.”
Customer voices and their transformation dominate the page ... clinician quotes, named health system outcomes, and case studies keep the customer as protagonist throughout.
- 2
14AI-Parmesan Index
“Proprietary, clinically validated algorithms to recommend diagnoses with evidence" / "16,209,383 Recommended diagnoses accepted by clinicians”
AI claims are grounded in a specific mechanism (clinically validated algorithms, evidence-based diagnosis recommendations) and a concrete adoption number rather than generic 'AI-powered' language.
- 2
15LLM Quotability
“Physicians only see 3% of data in the chart leading to missed diagnoses, sub-optimal care, and lost revenue. Regard reviews 100% to diagnose and document.”
This sentence is clean, declarative, statistic-anchored, and structured exactly as an LLM would lift it verbatim to explain what Regard does and why it matters.
- 2
16Copyright Freshness
“Jul 2026 ... Beyond the revenue cycle" / "May 2026 ... Getting Documentation Right the First Time”
Blog/news posts are dated mid-2026 and the Summit references 2027, giving clear recency signals that AI engines and human buyers can both validate.
- 2
17Entity Distinctiveness
“Your revenue problem is a diagnosis problem" + "Physicians only see 3% of data" + "reviews 100% to diagnose and document”
The 3%-vs-100% reframe, the revenue-as-diagnosis-problem hook, and the HCC/CC/MCC specificity make Regard's positioning unmistakably distinct from generic CDI or ambient documentation competitors.
- 0
18AI Recommendation Check
“AI's picks: Nuance DAX, Abridge, Suki, Ambience Healthcare, Augmedix, 3M Health Information Systems. You were not named.”
We asked AI who it recommends for "Chief Medical Information Officer, CMO, or VP of Revenue Cycle at a mid-to-large U.S. health system" looking for "AI-powered clinical documentation and diagnosis intelligence software for health systems". It named Nuance DAX, Abridge, Suki, Ambience Healthcare, Augmedix. You did not appear. AI can't recommend what it can't clearly understand.
Conversion Signal
1 signal
- 1
19Path & CTA Clarity
“[Request a demo]" and "[See how it works]" ... no numbered process or step-by-step path visible on the page.”
There is a clear primary CTA (Request a demo) and a soft secondary (See how it works), but no numbered process explaining how a buyer gets from interest to value ... half the criterion is met.
Your move
Think Regard’s score is wrong? Good. Let’s look at it together.
Twenty minutes with Greg. Bring the page, bring the argument. You’ll leave knowing exactly which signal is costing Regard the AI recommendation, and what to write instead.
Not on the list? Run your homepage through the free Brand Signal Score and see where you’d land. Same 19 signals, same AI check, two minutes.